Deficiencias en las hojas de información de estudios genómicos
- Sáenz de Tejada López, Marta
- Valle Mansilla, José Ignacio
- Ruiz-Canela López, Miguel
ISSN: 1132-1989, 2386-3773
Year of publication: 2010
Volume: 21
Issue: 71
Pages: 95-108
Type: Article
More publications in: Cuadernos de bioética
Abstract
Introduction: whenever biological samples are requested for genomic research consent from donors is always needed. In this process, appropriate information offered to participants is essential. The aim of this study is to assess the information included in consent forms from genomic studies. Material and Methods: a 51-item checklist was used to perform a content analysis of consent forms offered to sample donors. We included all consent forms used in genomic research projects approved by an Ethics Review Committee between 2004 and 2007. Results: consent forms from 68 genomic studies were reviewed. 58 (85%) of those were international studies and promoted by the pharmaceutical industry. We found some important defi ciencies in the consent forms on the information related to the sample’s use: less than 50% mentioned aspects related to the ownership of the sample, the free donation of the sample or the place of sample storage. There have also been frequent omissions related to the genetic data such as the right to know the results of the research, the disclosure of information to family members or the length of time during which these genetic data will be stored. Conclusions: important omissions have been found in the assessed consent forms on aspects related to the use of samples and genetic data. Therefore, a substantial improvement should be undertaken in the consent forms in order to comply both with the requirements established in the Spanish biomedical law and the ethical demands.
Bibliographic References
- Guttmacher AE, Collins S. Genomic medicine--a primer. N Engl J Med 2002; 347: 1512-20.
- Shurin SB, Nabel E. Pharmacogenomics – Ready for prime time? N Engl J Med 2008; 358: 1061-3.
- Eichelbaum M, Ingelman-Sundberg M, Evans W.E. Pharmacogenomics And Individualized Drug Therapy. Annu. Rev. Med. 2006. 57:119-37.
- Evans W.E., McLeod H.L. Pharmacogenomics- Drug disposition, drug targets and side effects. N Eng J Med 2003; (348)6: 538-549.
- Kapp MB. Ethical and legal issues in research involving human subjects: do you want a piece of me? J Clin Pathol. 2006; 59: 335-339.
- Lunshoff JE, Chadwick R, Vorhaus DB, Church GM. From genetic privacy to open consent. Nature Rev Genet 2008; 9:406-11.
- Ruiz-Canela M. Farmacogenómica: un nuevo desafío para la ética de la investigación. Junta General del Principado de Asturias-Sociedad Internacional de Bioética: Gijón, 2005.
- Touret C. New European guidelines for the use of stored human biological materials in biomedical research. J Med Ethics 2004; 30; 99-103.
- Asenjo Sebastián MA, Bohigas Santasusagna Ll, Trilla García A, Prat Marín A. Gestión diaria del Hospital. Elsevier España, 2007.
- Rodríguez-Villanueva J, Alsar MJ, Avendaño C. Estudios farmacogenéticos: guía de evaluación para comités éticos de investigación clínica. Fundamentos científicos y marco legal (I). Med Clin (Barc) 2003; 120:63-7.
- Rodríguez-Villanueva J, Alsar MJ, Avendaño C. Estudios farmacogenéticos: guía de evaluación para comités éticos de investigación clínica. Protocolo y hoja de información al paciente (II). Med Clin (Barc) 2003; 120:101-7.